Bupropion Hydrochloride
Product Images NDC 76519-1021

2 FDA label images from H.j. Harkins Company Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 76519-1021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

76519 1021.jpg (76519 1021)

76519 1021.jpg (76519 1021)
Label for BUPROPION HCL ER(XL) 150mg tablets shows multiple listings of the drug name, NDC number 76519-1021-XX, expiration date 08/31/19, lot number I1708852, and manufacturer NDC 69097-0875-02 (Cipla). It includes a caution about federal law prohibiting transfer except to the prescribed person, storage instructions, and a directive to take as directed by a physician. The label is repacked by H.J. Harkins Company Inc., Grover Beach, CA.*
FDA Label Image

Bupropion.jpg (Bupropion)

Bupropion.jpg (Bupropion)
Chemical structure of bupropion hydrochloride, showing the molecular arrangement including a chlorophenyl ring, ketone group, and tert-butylamino group, associated with hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.